Innovacell runs one of the largest facilities in Europe for the production of autologous cell therapies, with the capacity to produce around 2,500 units per year. The plant is certified to the current standards of Good Manufacturing Practice (GMP). If demand should call for it, the capacity can be doubled within six months.
In addition, the enterprise operates a state-of-the-art cryo-preservation unit which allows it to store, handle and transport cell-cultures to the highest possible safety levels. Innovacell's production facilities and offices are located in the Science Park, Innsbruck.